Floré Unveils World’s First Line of Probiotics for Neurodiversity
WEB5 hours ago · SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Floré, a leader in gut health testing and customized probiotics, has launched its new line of probiotics specifically designed for neurodiversity. The new products, Pathways Support and Mood Support are formulated using extensive data from the company’s groundbreaking research …
Labviva Introduces Real Time Inventory Management System for …
WEB5 hours ago · Enterprise procure-to-payment provider advances AI automation for inventory and purchase intelligence. BOSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Labviva, the leading AI procurement platform for life sciences, today announced the general availability of its automated Inventory Management System (IMS), a core feature of …
Safety Shot Partners with Launchpad to Tap into the Large and ...
WEB5 hours ago · Launchpad’s Network All Roads Travel (ART) Will Help Raise Brand Awareness for Safety Shot Among Millions of U.S. College Students. JUPITER, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”), a wellness company behind the first patented wellness product on Earth that lowers blood alcohol content in as little as 30 minutes by ...
Expanded Health Policies Enhance TMS Therapy Access for …
WEB5 hours ago · Effective immediately, BlueCross BlueShield (BCBS) of North Carolina has expanded its TMS policy to cover adolescents 15 years and older, based on recent clearance from the United States Food and Drug Administration (FDA) for NeuroStar as the first and only TMS treatment authorized for this population. BCBC of …
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and …
WEB5 hours ago · Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an entirely new precision oncology assay for breast cancer treatment decision making utilizing the Reverse Phase Protein Array (RPPA) technology through its newly established subsidiary ...
Bright Minds Biosciences to Host Investor & Analyst KOL Event on ...
WEB5 hours ago · 19-09-2024. Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and will discuss the details of the BREAKTHROUGH clinical trial on September 25th. The event will feature Epilepsy KOLs to discuss the unmet needs for epilepsy treatment.
Actualité des professionnels de santé | Santé log
WEB39€ TTC. / 7 Numéros. Format numérique. Format PDF ( revue imprimable ) Découvrez la revue. Santé log site dédié à l'actualité des professionnels de santé. Santé log apporte une information pertinente et de qualité sur l'actualité médicale.
FibroBiologics Engages Southern Star Research as CRO in Australia
WEB5 hours ago · 19-09-2024. Southern Star Research will provide CRO services for FibroBiologics in Australia. HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...
Pfizer and BioNTech Provide Update on mRNA-based …
WEBAug 16, 2024 · NEW YORK and MAINZ, Germany, August 16, 2024 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and COVID-19 in ...
Dossiers - santé log
WEBCréer votre compte gratuitement. Retrouvez les dossiers thématiques de Santé log dans cet espace. Pour accéder aux dossiers complets vous devez vous identifier en créant votre compte.